Results 221 to 230 of about 28,374 (231)

18 F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's disease

EMBO Molecular Medicine, 2017
Niklas Mattsson, Michael Schöll, Ruben Smith   +2 more
exaly  

Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies

Nature Reviews Drug Discovery, 2009
Kurt R Brunden, John Trojanowski, Virginia M-Y Lee   +2 more
exaly  

Tau pathology spread in PS19 tau transgenic mice following locus coeruleus (LC) injections of synthetic tau fibrils is determined by the LC’s afferent and efferent connections

Acta Neuropathologica, 2015
Jennifer D Mcbride, Jing L Guo, Bin Zhang   +2 more
exaly  

Tau stabilizes microtubules by binding at the interface between tubulin heterodimers

Proceedings of the National Academy of Sciences of the United States of America, 2015
Harindranath Kadavath, Jacek Biernat, Henning Urlaub   +2 more
exaly  

Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain

Brain, 2015
Nicole Maphis, Shanya Jiang, Astrid E Cardona   +2 more
exaly  

SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination

Proceedings of the National Academy of Sciences of the United States of America, 2014
Gang Yin, Keqiang Ye, Xiao-Chuan Wang
exaly  

Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases

Nature Reviews Drug Discovery, 2007
Peter M Fischer
exaly  

Cellular and pathological functions of tau

Nature Reviews Molecular Cell Biology
Celeste Parra Bravo, Li Gan
exaly  

A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity

Acta Neuropathologica, 2014
Jane Cooper, Samira Parhizkar, Annalisa Cavallini   +2 more
exaly  

Neuronal uptake of tau/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer‘s disease

Brain, 2014
exaly